ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : accessory cells
Scheme : NHMRC Project Grants
Clear All
Filter by Field of Research
Medical and Health Sciences (47)
Clinical chemistry (incl. diagnostics) (34)
Cellular Immunology (31)
Haematology (27)
Respiratory Diseases (17)
Clinical sciences not elsewhere classified (13)
Endocrinology (13)
Reproduction (12)
Cell Development (Incl. Cell Division And Apoptosis) (11)
Diagnostic radiography (10)
Applied immunology (incl. antibody engineering xenotransplantation and t-cell therapies) (9)
Cell Development, Proliferation and Death (9)
Gastroenterology and Hepatology (8)
Immunology (8)
Emergency medicine (7)
Nutrigenomics and personalised nutrition (7)
Nutritional science (7)
Dermatology (6)
Genetic Development (Incl. Sex Determination) (6)
Medical Virology (6)
Nephrology And Urology (6)
Regenerative Medicine (incl. Stem Cells and Tissue Engineering) (6)
Anaesthesiology (5)
Nephrology and Urology (5)
Biochemistry and Cell Biology not elsewhere classified (4)
Developmental Genetics (incl. Sex Determination) (4)
Infectious Diseases (4)
Oncology And Carcinogenesis (4)
Oncology and Carcinogenesis (4)
Orthopaedics (4)
Filter by Socio-Economic Objective
Search did not return any results.
Filter by Funding Provider
National Health and Medical Research Council (592)
Filter by Status
Closed (592)
Filter by Scheme
NHMRC Project Grants (592)
Filter by Country
Australia (23)
Filter by Australian State/Territory
NSW (7)
VIC (7)
QLD (5)
ACT (3)
WA (3)
  • Researchers (0)
  • Funded Activities (592)
  • Organisations (44)
  • Funded Activity

    A Study Of Blood Cells Which Kill Microorganisms And In Cite Immunity

    Funder
    National Health and Medical Research Council
    Funding Amount
    $234,649.00
    More information
    Funded Activity

    The Role Of Cell Surface Molecules In Determining The Immune Response

    Funder
    National Health and Medical Research Council
    Funding Amount
    $115,207.00
    More information
    Funded Activity

    Interaction Of Cell Surface Molecules Used By Viruses T O Enter Cells

    Funder
    National Health and Medical Research Council
    Funding Amount
    $335,671.00
    More information
    Funded Activity

    The Hepatitis B Virus Receptor

    Funder
    National Health and Medical Research Council
    Funding Amount
    $181,330.00
    More information
    Funded Activity

    The Role Of Vif In Enhancing HIV Replication And Effecting The Integrity Of The Replication Complexes Of HIV

    Funder
    National Health and Medical Research Council
    Funding Amount
    $260,200.00
    Summary
    HIV-AIDS is still one of the leading causes of infectious human fatality worldwide. The genome of HIV encodes six viral accessory proteins that are necessary for viral replication and infection. One of these genes, viral infectivity factor (vif), is essential for production of infectious virus. Exactly how this viral protein works within the cell is not clear at present. Current literature suggests that Vif acts in some way to enhance reverse transcription, one of the early stages of the viral l .... HIV-AIDS is still one of the leading causes of infectious human fatality worldwide. The genome of HIV encodes six viral accessory proteins that are necessary for viral replication and infection. One of these genes, viral infectivity factor (vif), is essential for production of infectious virus. Exactly how this viral protein works within the cell is not clear at present. Current literature suggests that Vif acts in some way to enhance reverse transcription, one of the early stages of the viral life cycle. We aim to investigate the action of Vif in stabilizing early HIV reverse transcription complexes to understand how it acts to enhance HIV replication and viral infection. The early stages of HIV replication are critical for establishing infection and hence ideal targets for therapeutic intervention. This research will help understand how Vif works in a cell and affects the infectivity of HIV viral particles and may be suggestive of potential targets for development of anti-viral drugs.
    Read more Read less
    More information
    Funded Activity

    Brainstem Mechanisms Controlling Hormone Secretion

    Funder
    National Health and Medical Research Council
    Funding Amount
    $249,509.00
    More information
    Funded Activity

    The Role Of Cognate And Innate Immune Mechanisms In Cellular Xenograft Rejection

    Funder
    National Health and Medical Research Council
    Funding Amount
    $231,790.00
    More information
    Funded Activity

    Inhibition Of Alloreactivity By Modulation Of Antigen Presenting Cells

    Funder
    National Health and Medical Research Council
    Funding Amount
    $504,097.00
    Summary
    Bone marrow transplantation (BMT) is the most effect treatment for a number of conditions, especially leukemia. Graft versus host disease (GVHD) is a complication of BMT and results in the death of up to 50% of transplant recipients. GVHD occurs when the newly transplanted immune system recognizes the recipient as foreign and mounts and immune reponse against the patients tissues. These studies will focus on identifying and understanding the function of the immune cells which drive GVHD.
    More information
    Funded Activity

    Immunoregulatory T Cells And Tumour Immunity

    Funder
    National Health and Medical Research Council
    Funding Amount
    $212,036.00
    Summary
    Cancer is one of the leading causes of death in the industrialized world. While therapies to treat cancer have continued to improve one area that, in theory at least, shows great promise in the treatment of tumours is manipulating the immune system to effectively recognize and destroy cancerous lesions. Experiments in human and animal systems have clearly shown that the immune system has the potential to respond to tumour cells and trials of tumour vaccines are underway. It has recently become a .... Cancer is one of the leading causes of death in the industrialized world. While therapies to treat cancer have continued to improve one area that, in theory at least, shows great promise in the treatment of tumours is manipulating the immune system to effectively recognize and destroy cancerous lesions. Experiments in human and animal systems have clearly shown that the immune system has the potential to respond to tumour cells and trials of tumour vaccines are underway. It has recently become apparent that the immune responses to tumours may be inhibited by classes of regulatory immune cells. Eliminating these cells results in a more vigorous and effective anti-tumour response. This project will seek to discover the mechanisms of action of theses regulatory immune cells in order to devise more effective anti-cancer vaccines and therapies.
    Read more Read less
    More information
    Funded Activity

    Growth Factor Mobilised PBPC; Clinical Studies And Biological Characterization

    Funder
    National Health and Medical Research Council
    Funding Amount
    $150,984.00
    More information

    Showing 1-10 of 592 Funded Activites

    • 1
    • 2
    • 3
    • 4
    • 5
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback